Corporate Governance

Mediclinic is committed to maintaining strict principles of good corporate governance and the highest standards of integrity and ethics. The Board accepts full responsibility for corporate governance and is committed to ensuring a high standard of discipline, independence, ethics, equity, social responsibility, accountability, cooperation and transparency.

The Board is satisfied that the Company, as a company registered in accordance with the laws of England and Wales with a primary listing on the London Stock Exchange, meets the requirements of the United Kingdom Companies Act of 2006, the United Kingdom Listing Authority’s Listing Rules and the majority of the principles of the United Kingdom Corporate Governance Code issued by the Financial Reporting Council, most recently updated in July 2018. 

As the Company also has a secondary listing on the JSE Ltd (“JSE”), the South African stock exchange, the Company meets all relevant requirements of the JSE Listings Requirements. The Company’s application of the governance principles contained in the United Kingdom Corporate Governance Code, alternatively an explanation of the non-application thereof, is reported on annually in the Company’s annual report, available in the  Investor Relations section of the website.

Articles of Association

The Company is further governed by its Articles of Association. A rigorous policy review of the pre-takeover policies of the Company and Mediclinic International plc will be conducted by the Board to ensure the continued application of the Group’s governance standards.

Board Committees

In accordance with the United Kingdom Corporate Governance Code, the Board has established certain Board Committees which have defined tasks in terms of approved terms of reference.

Corporate Governance Reports

A corporate governance report is issued annually and included within the annual report. Please visit the Investor Relations section for the latest and previous reports.